DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Lucinactant
Lucinactant
Synthetic Surfactants: Where Are We? Evidence from Randomized, Controlled Clinical Trials
Lucinactant Attenuates Pulmonary Inflammatory Response, Preserves Lung Structure, and Improves Physiologic Outcomes in a Preterm Lamb Model of RDS
Miscibility of Egg Yolk Lecithin with Palmitic Acid and Hexadecanol At
What's New in Surfactant?
Is There a Difference in Surfactant Treatment
Animal-Derived Surfactants for the Treatment and Prevention of Neonatal Respiratory Distress Syndrome: Summary of Clinical Trials
Windtree Therapeutics Company Overview August 20, 2020 OTCQB:(NASDAQ: WINT) WINT Forward-Looking Statements
Comparative Efficacy of Pulmonary Surfactant in Respiratory Distress Syndrome in Preterm Infants: a Bayesian Network Meta-Analysis
Surfactant Replacement Therapy: 2013
An Overview of Acute Lung Injury in General and in Particular Viral
Comparison of Poractant Alfa and Lyophilized Lucinactant in a Preterm Lamb Model of Acute Respiratory Distress
Exogenous Surfactant Therapy in Pediatrics
Label Portion of the Trial (Part A) and 102 Patients Participated in a Subsequent Randomized Controlled Portion (Part B)
Surfactant Therapy for Bronchiolitis in Critically Ill Infants (Review)
Emerging Advances of Nanotechnology in Drug and Vaccine Delivery Against Viral Associated Respiratory Infectious Diseases (VARID)
Surfactant Preparations for Preterm Infants with Respiratory Distress Syndrome: Past, Present, and Future
Update in Surfactant Therapy Susan Guttentag and Cherie D
Top View